3. Pathways for Management of cervical cancer

The The Uterus-11 trial, (NCT01049100) a multicenter phase III Intergroup trial of the German Radiation Oncology Group (ARO) and the Gynecologic Cancer Group (AGO) was designed to evaluate the role of surgical staging in patients with stage IIB-IV cervical cancer before primary chemoradiation therapy within a prospective randomised design. ................
................